Enveric Biosciences
ENVB • NASDAQ
Enveric Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joseph Edward Tucker, with a market cap of $2.6M.
CEOJoseph Edward Tucker
Next Earnings
Upcoming earnings announcement for Enveric Biosciences
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for Enveric Biosciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Q4 2025 | -$0.50 | — | - | — |  10-K |
| Nov 14, 2025 | Q3 2025 | -$10.81 | — | - | — | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.97 | — | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$1.22 | — | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$4.83Est: -$6.00 | +19.5% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$3.60Est: -$7.80 | +53.8% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$3.45Est: -$8.25 | +58.2% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$9.15Est: -$19.20 | +52.3% | - | — | 10-Q |
| Mar 26, 2024 | Q4 2023 | -$22.05Est: -$23.10 | +4.5% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$19.50Est: -$31.35 | +37.8% | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$45.60Est: -$9.75 | -367.7% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$34.65 | — | - | — | — |